Eco Animal Health Group Plc Market Cap ($775.42K)
Market Cap & Net Worth: Eco Animal Health Group Plc (EAH)
Eco Animal Health Group Plc market cap. Eco Animal Health Group Plc (LSE:EAH) has a market capitalization of $775.42K (GBX6.37 Billion) as of November 6, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30816 globally and #846 in its home market, demonstrating a -0.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eco Animal Health Group Plc's stock price GBX95.00 by its total outstanding shares 67084671 (67.08 Million). Also see Eco Animal Health Group Plc cash conversion from operations for how efficiently the company converts equity into cash flow.
Eco Animal Health Group Plc Market Cap History (2015–2026)
Eco Animal Health Group Plc market cap history from 2015 to 2026. Data shows change from $2.38 Million to $775.42K (-8.97% CAGR). Check Eco Animal Health Group Plc (EAH) stock price for real-time trading data and today's change.
Index Memberships
Eco Animal Health Group Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$992.58 Million | 0.08% | #176 of 722 |
Weight: Eco Animal Health Group Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Eco Animal Health Group Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eco Animal Health Group Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Eco Animal Health Group Plc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Eco Animal Health Group Plc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.51x
Eco Animal Health Group Plc's market cap is 0.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.84 Million | $47.14 Million | $6.04 Million | 0.08x | 0.64x |
| 2017 | $4.60 Million | $61.42 Million | $10.56 Million | 0.07x | 0.44x |
| 2018 | $3.24 Million | $67.20 Million | $9.31 Million | 0.05x | 0.35x |
| 2019 | $1.68 Million | $67.25 Million | $7.25 Million | 0.03x | 0.23x |
| 2020 | $2.01 Million | $72.11 Million | $3.90 Million | 0.03x | 0.52x |
| 2021 | $1.31 Million | $105.61 Million | $7.34 Million | 0.01x | 0.18x |
| 2022 | $824.39K | $82.19 Million | -$686.00K | 0.01x | N/A |
| 2023 | $885.61K | $85.31 Million | $1.01 Million | 0.01x | 0.88x |
| 2024 | $579.52K | $89.42 Million | $1.05 Million | 0.01x | 0.55x |
| 2025 | $852.96K | $79.60 Million | $1.69 Million | 0.01x | 0.51x |
Competitor Companies of EAH by Market Capitalization
Companies near Eco Animal Health Group Plc in the global market cap rankings as of November 6, 2026. Also see Eco Animal Health Group Plc total assets for a full breakdown of the balance sheet.
Key companies related to Eco Animal Health Group Plc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #506 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #532 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.40 |
| #570 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.85 Billion | CN¥50.19 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €19.30 |
Market Capitalization of Eco Animal Health Group Plc (2015–2026)
Market capitalization of Eco Animal Health Group Plc from 2015 to today. Between 2015 and today, Eco Animal Health Group Plc's market cap moved from $2.38 Million to $ 775.42K, with a yearly change of -8.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX775.42K | -9.09% |
| 2025 | GBX852.96K | +47.18% |
| 2024 | GBX579.52K | -34.56% |
| 2023 | GBX885.61K | +7.43% |
| 2022 | GBX824.39K | -36.88% |
| 2021 | GBX1.31 Million | -35.15% |
| 2020 | GBX2.01 Million | +19.57% |
| 2019 | GBX1.68 Million | -48.04% |
| 2018 | GBX3.24 Million | -29.50% |
| 2017 | GBX4.60 Million | +19.78% |
| 2016 | GBX3.84 Million | +61.45% |
| 2015 | GBX2.38 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Eco Animal Health Group Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $775.42K USD |
| MoneyControl | $775.42K USD |
| MarketWatch | $775.42K USD |
| marketcap.company | $775.42K USD |
| Reuters | $775.42K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eco Animal Health Group Plc
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatm… Read more